TuHURA Biosciences, Inc.
HURA
$3.25
$0.3411.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -42.91% | -11.15% | -- | -- | -8.74% |
| Total Depreciation and Amortization | -4.96% | -19.89% | -- | -- | 3.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 2,318.39% |
| Total Other Non-Cash Items | -1.24% | 32.00% | -- | -- | 93.05% |
| Change in Net Operating Assets | 280.81% | -77.10% | -- | -- | -238.80% |
| Cash from Operations | -31.86% | -82.27% | -- | -- | -32.12% |
| Capital Expenditure | 86.89% | -99.53% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 86.39% | 81.51% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 86.40% | -39.77% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | 188.90% |
| Total Debt Repaid | 200.00% | 30.98% | -- | -- | -- |
| Issuance of Common Stock | 1,691.17% | 3,553.62% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -76.28% | 81.70% | -- | -- | -345.43% |
| Cash from Financing | 1,687.44% | 84.42% | -- | -- | 179.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 135.62% | 7.23% | -- | -- | 885.54% |